First Time Loading...
X

Xenon Pharmaceuticals Inc
NASDAQ:XENE

Watchlist Manager
Xenon Pharmaceuticals Inc
NASDAQ:XENE
Watchlist
Price: 44 USD 0.57%
Updated: May 6, 2024
Section:
 

Wall Street
Price Targets

XENE Price Targets Summary
Xenon Pharmaceuticals Inc

Wall Street analysts forecast XENE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for XENE is 59.26 USD with a low forecast of 50.5 USD and a high forecast of 68.25 USD.

XENE Lowest Forecast
Wall Street Target
50.5 USD
15% Upside
XENE Average Forecast
Wall Street Target
59.26 USD
35% Upside
XENE Highest Forecast
Wall Street Target
68.25 USD
55% Upside
Lowest
Price Target
50.5 USD
15% Upside
Average
Price Target
59.26 USD
35% Upside
Highest
Price Target
68.25 USD
55% Upside
Xenon Pharmaceuticals Inc Competitors:
Price Targets
BBIO
BridgeBio Pharma Inc
82% Upside
ABBV
Abbvie Inc
15% Upside
ICCC
ImmuCell Corp
178% Upside
OCX
OncoCyte Corp
56% Upside
BBIO
BridgeBio Pharma Inc
82% Upside
ABBV
Abbvie Inc
15% Upside
ICCC
ImmuCell Corp
178% Upside
OCX
OncoCyte Corp
56% Upside
ALPRE
Predilife SA
56% Upside
688687
Beijing Kawin Technology Share-holding Co Ltd
26% Upside
IVA
Inventiva SA
269% Upside
A
ALVO
Alvotech SA
17% Upside

Revenue
Forecast

Revenue Estimate
Xenon Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-17%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Xenon Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Xenon Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-55%
Average Miss
What are analyst estimates?

See Also

Summary
XENE intrinsic value, competitors valuation, and company profile.
DCF Valuation
XENE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
XENE stock valuation using valuation multiples.
Wall Street Estimates
XENE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
XENE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is XENE's stock price target?
Price Target
59.26 USD

According to Wall Street analysts, the average 1-year price target for XENE is 59.26 USD with a low forecast of 50.5 USD and a high forecast of 68.25 USD.

ALPHA SPREAD
Join more than 134,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.